RxDoctor Payments Data

Vanessa Gonzales

Nurse Practitioner · Rio Rancho, NMNPI 1801513650

Payments from drug & device makers

$640in general payments, 2019–2025

Across 30 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$318
  • Lilly USA, LLC$113
  • Amgen$53
  • Boehringer Ingelheim$45
  • Novo Nordisk$36
  • GSK$26
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$640100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$640 in reported general payments places this provider in the 80th percentile of 624 nurse practitioner providers in New Mexico.

See all nurse practitioner providers in New Mexico

Medicare billing

Part B allowed, 2024
$3,645
Medicare patients
49
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide30$34,959
OzempicSemaglutide28$33,316
MounjaroTirzepatide19$27,880
Tresiba Flextouch U-200Insulin Degludec18$23,631
Tresiba Flextouch U-100Insulin Degludec26$21,935
JanuviaSitagliptin Phosphate25$18,309
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/716$15,591
JardianceEmpagliflozin15$11,233
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$3,755
Insulin Aspart FlexpenInsulin Aspart17$3,692
Insulin Aspart11$2,390
Insulin Glargine-Yfgn16$1,869
Testosterone11$1,037
Levothyroxine Sodium75$792
Glimepiride41$539

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$113$62,83949 claims
Novo NordiskOzempic$36$33,31628 claims
MerckJanuvia$14$18,30925 claims
Boehringer IngelheimJardiance$45$11,23315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 624 nurse practitioner providers in New Mexico.

Other nurse practitioner in Rio Rancho

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →